Biotron (Biotron) Total Liabilities : $0.42 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Biotron Total Liabilities?

Biotron's Total Liabilities for the quarter that ended in Dec. 2023 was $0.42 Mil.

Biotron's quarterly Total Liabilities increased from Dec. 2022 ($0.54 Mil) to Jun. 2023 ($0.65 Mil) but then declined from Jun. 2023 ($0.65 Mil) to Dec. 2023 ($0.42 Mil).

Biotron's annual Total Liabilities increased from Jun. 2021 ($0.36 Mil) to Jun. 2022 ($0.57 Mil) and increased from Jun. 2022 ($0.57 Mil) to Jun. 2023 ($0.65 Mil).

Biotron Total Liabilities Historical Data

The historical data trend for Biotron's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotron Total Liabilities Chart

Biotron Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Liabilities

Get a 7-Day Free Trial

0.29

0.59

0.36

0.57

0.65

Biotron Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															0.45	0.57	0.54	0.65	0.42

Biotron Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Biotron's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.642	+	(0.005	+	-0.001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.65

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	2.775	-	2.13
	=	0.65

Biotron's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.419	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.42

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	1.67	-	1.251
	=	0.42

Biotron Total Liabilities Related Terms

Thank you for viewing the detailed overview of Biotron's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotron (Biotron) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotron Ltd (OTCPK:BITRF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

BIT:Australia

Address

56 Delhi Road, Suite 3.3, North Ryde, Sydney, NSW, AUS, 2113

Website

https://www.biotron.com.au

Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

Biotron (Biotron) Headlines

From GuruFocus

Biotron Drug Effective Against COVID-19 In Animals

By PRNewswire PRNewswire • 11-25-2021